drugset / Trial / NCT00571727
Long-Term Treatment With rhIGF-1 in GHIS
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study was to evaluate the long-term safety and effectiveness of mecasermin (the study drug) in children with growth failure due to severe Primary insulin-like growth factor-1 deficiency (Primary IGFD).
Timeline
- Start
- 1991-05-20
- Primary completion
- 2011-12-15
- Completion
- 2011-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mecasermin | Protein / enzyme biologic | 60 ug/kg | Subcutaneous |
| Subject | mecasermin | Protein / enzyme biologic | 120 ug/kg | Subcutaneous |